{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:02:57Z","timestamp":1785074577134,"version":"3.55.0"},"reference-count":270,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG-KFO325"],"award-info":[{"award-number":["DFG-KFO325"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189614","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:24:32Z","timestamp":1778891072000},"page":"189614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging concepts, hot topics, and open questions in today\u2019s pancreatic cancer research"],"prefix":"10.1016","volume":"1881","author":[{"given":"Corinna","family":"Keber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Visekruna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brichkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke Pogge","family":"von Strandmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg W.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta-Maria","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Gress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Lauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2025","key":"10.1016\/j.bbcan.2026.189614_bb0005","first-page":"10","article-title":"CA Cancer","volume":"75","author":"Siegel","year":"2025","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bbcan.2026.189614_bb0010","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0015","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2026.189614_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15092614","article-title":"A quick guide to CAF subtypes in pancreatic cancer","volume":"15","author":"Brichkina","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189614_bb0030","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41571-022-00612-6","article-title":"The role of neoadjuvant therapy for resectable pancreatic cancer remains uncertain","volume":"19","author":"Springfeld","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0050","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2022.3829","article-title":"Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial","volume":"8","author":"Conroy","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","article-title":"Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial","volume":"8","author":"Ghaneh","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S2468-1253(20)30330-7","article-title":"Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial","volume":"6","author":"Kunzmann","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0065","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0070","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0075","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0080","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial","volume":"402","author":"Wainberg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2026.189614_bb0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","article-title":"Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial","volume":"387","author":"Wang-Gillam","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2026.189614_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/gutjnl-2023-330480","article-title":"Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer","volume":"73","author":"van Eijck","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb0095","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2023.01.022","article-title":"Increasing pancreatic cancer incidence in young women in the United States: a population-based time-trend analysis, 2001-2018","volume":"164","author":"Abboud","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0105","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2026.189614_bb0110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","article-title":"Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution","volume":"52","author":"Chan-Seng-Yue","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2026.189614_bb0120","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","article-title":"Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features","volume":"155","author":"Puleo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.743908","article-title":"Clinical impact of molecular subtyping of pancreatic cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0130","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-20-0133","article-title":"Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes","volume":"10","author":"Miyabayashi","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0135","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","article-title":"Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment","volume":"54","author":"Hwang","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2026.189614_bb0140","first-page":"318","article-title":"Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment","volume":"3","author":"Falcomat\u00e0","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189614_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/1078-0432.CCR-19-1467","article-title":"Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer","volume":"26","author":"Rashid","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0150","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0155","doi-asserted-by":"crossref","unstructured":"A.J. Aguirre, J.A. Nowak, N.D. Camarda, R.A. Moffitt, A.A. Ghazani, M. Hazar-Rethinam, S. Raghavan, J. Kim, L.K. Brais, D. Ragon, M.W. Welch, E. Reilly, D. McCabe, L. Marini, K. Anderka, K. Helvie, N. Oliver, A. Babic, A. Da Silva, B. Nadres, E.E. van Seventer, H.A. Shahzade, J.P. St Pierre, K.P. Burke, T. Clancy, J.M. Cleary, L.A. Doyle, K. Jajoo, N.J. McCleary, J.A. Meyerhardt, J.E. Murphy, K. Ng, A.K. Patel, K. Perez, M.H. Rosenthal, D.A. Rubinson, M. Ryou, G.I. Shapiro, E. Sicinska, S.G. Silverman, R.J. Nagy, R.B. Lanman, D. Knoerzer, D.J. Welsch, M.B. Yurgelun, C.S. Fuchs, L.A. Garraway, G. Getz, J.L. Hornick, B.E. Johnson, M.H. Kulke, R.J. Mayer, J.W. Miller, P.B. Shyn, D.A. Tuveson, N. Wagle, J.J. Yeh, W.C. Hahn, R.B. Corcoran, S.L. Carter, B.M. Wolpin, Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine, Cancer Discov. 8 (2018) 1096\u20131111. doi:https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0275.","DOI":"10.1158\/2159-8290.CD-18-0275"},{"key":"10.1016\/j.bbcan.2026.189614_bb0160","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/bjs\/znac272","article-title":"Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study","volume":"109","author":"Suurmeijer","year":"2022","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.bbcan.2026.189614_bb0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1200\/JCO.22.02668","article-title":"Prediction of adjuvant gemcitabine sensitivity in resectable pancreatic adenocarcinoma using the GemPred RNA signature: an ancillary study of the PRODIGE-24\/CCTG PA6 clinical trial","volume":"42","author":"Nicolle","year":"2024","journal-title":"JCO"},{"key":"10.1016\/j.bbcan.2026.189614_bb0170","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1053\/j.gastro.2019.02.037","article-title":"Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0175","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0180","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jamaoncol.2023.2761","article-title":"Avelumab vs standard second-line chemotherapy in patients with metastatic colorectal cancer and microsatellite instability: a randomized clinical trial","volume":"9","author":"Ta\u00efeb","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0190","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0195","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1158\/2159-8290.CD-21-1119","article-title":"Zenocutuzumab, a HER2xHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements","volume":"12","author":"Schram","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/gutjnl-2019-319984","article-title":"DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives","volume":"70","author":"Perkhofer","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.116065","article-title":"Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: a Nationwide prospective cohort study","volume":"230","author":"Strijk","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0210","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0215","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189614_bb0220","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0225","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0230","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1101\/gad.2016111","article-title":"Pancreatic cancers require autophagy for tumor growth","volume":"25","author":"Yang","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189614_bb0235","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1158\/2159-8290.CD-22-0043","article-title":"NCOA4-mediated ferritinophagy is a pancreatic cancer dependency via maintenance of iron bioavailability for iron-sulfur cluster proteins","volume":"12","author":"Santana-Codina","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0240","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0245","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0255","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-19-1167","article-title":"The KRASG12C inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients","volume":"10","author":"Hallin","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0260","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of RAS mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0265","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s42004-025-01662-4","article-title":"Discovery of KRAS(G12D) selective degrader ASP3082","volume":"8","author":"Yoshinari","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.bbcan.2026.189614_bb0270","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRASG12D Inhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189614_bb0275","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","article-title":"Efficacy of a small-molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer","volume":"13","author":"Kemp","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0285","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41586-024-07205-6","article-title":"Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy","volume":"629","author":"Holderfield","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0290","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/2159-8290.CD-24-0027","article-title":"Translational and therapeutic evaluation of RAS-GTP inhibition by RMC-6236 in RAS-driven cancers","volume":"14","author":"Jiang","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0295","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41586-024-07379-z","article-title":"Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer","volume":"629","author":"Wasko","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0300","article-title":"KRAS G12D -specific targeting with engineered exosomes reprograms the immune microenvironment to enable efficacy of immune checkpoint therapy in PDAC patients","author":"LeBleu","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.bbcan.2026.189614_bb0305","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.1812963116","article-title":"Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS\u2013SOS1 interaction","volume":"116","author":"Hillig","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189614_bb0310","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1158\/2326-6066.CIR-15-0188","article-title":"Identification of T-cell receptors targeting KRAS-mutated human tumors","volume":"4","author":"Wang","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0315","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41591-023-02760-3","article-title":"Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial","volume":"30","author":"Pant","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0320","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J. Immunother."},{"key":"10.1016\/j.bbcan.2026.189614_bb0325","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature25459","article-title":"Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes","volume":"554","author":"Mueller","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0330","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-021-04065-2","article-title":"Diverse alterations associated with resistance to KRAS(G12C) inhibition","volume":"599","author":"Zhao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0335","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn4180","article-title":"Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors","volume":"381","author":"Lv","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189614_bb0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cell.2014.06.003","article-title":"Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer","volume":"158","author":"Kapoor","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217258","article-title":"Macroautophagy\/autophagy promotes resistance to KRASG12D-targeted therapy through glutathione synthesis","volume":"604","author":"Han","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189614_bb0355","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ccell.2023.07.002","article-title":"KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells","volume":"41","author":"Mahadevan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0360","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1101\/gad.351037.123","article-title":"Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer","volume":"37","author":"Han","year":"2023","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189614_bb0365","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1158\/2159-8290.CD-24-1475","article-title":"T-cell dependency of tumor regressions and complete responses with RAS(ON) multi-selective inhibition in preclinical models of pancreatic ductal adenocarcinoma","volume":"15","author":"Orlen","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0370","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0375","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/imr.13273","article-title":"Hurdles race for CAR T-cell therapy in digestive tract cancer","volume":"320","author":"Kronig","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189614_bb0380","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa2119662","article-title":"Neoantigen T-Cell receptor gene therapy in pancreatic cancer","volume":"386","author":"Leidner","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0385","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8+ T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189614_bb0390","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0395","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0400","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0405","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0410","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/bjc.2013.32","article-title":"Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer","volume":"108","author":"Ino","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0415","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","article-title":"Neoantigen quality predicts immunoediting in survivors of pancreatic cancer","volume":"606","author":"\u0141uksza","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0420","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1016\/j.cell.2021.09.022","article-title":"Spatially confined sub-tumor microenvironments in pancreatic cancer","volume":"184","author":"Gr\u00fcnwald","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0425","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-\u03b3-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0430","first-page":"272","article-title":"Translational advances in pancreatic ductal adenocarcinoma therapy","volume":"3","author":"Hosein","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189614_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197307","article-title":"The immune microenvironment in pancreatic cancer","volume":"21","author":"Huber","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189614_bb0440","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/gutjnl-2018-316595","article-title":"Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma","volume":"68","author":"Raj","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb0445","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/s41467-021-21774-4","article-title":"Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma","volume":"12","author":"Sch\u00e4fer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0450","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0455","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0460","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0465","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1038\/s41591-025-03876-4","article-title":"Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results","volume":"31","author":"Wainberg","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0470","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12029-025-01165-4","article-title":"Advances in vaccine-based therapies for pancreatic cancer","volume":"56","author":"McMillan","year":"2025","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0475","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejca.2022.03.015","article-title":"Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: a phase I study","volume":"169","author":"Lau","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0480","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1200\/JCO.23.02585","article-title":"Dendritic cell-based immunotherapy in patients with resected pancreatic cancer","volume":"42","author":"van\u2019t Land","year":"2024","journal-title":"JCO"},{"key":"10.1016\/j.bbcan.2026.189614_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66092-1","article-title":"REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer","volume":"16","author":"Kucukcelebi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0490","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1158\/0008-5472.CAN-22-0094","article-title":"Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages","volume":"82","author":"Murgaski","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0495","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adp3978","article-title":"Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer","volume":"10","author":"Hogg","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0500","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1158\/1078-0432.CCR-22-1125","article-title":"Neoadjuvant chemotherapy is associated with altered immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer","volume":"28","author":"Costa","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0505","first-page":"1362","article-title":"Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC","volume":"4","author":"Zhou","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189614_bb0510","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189614_bb0515","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10585-021-10142-7","article-title":"The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma","volume":"39","author":"Kawahara","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbcan.2026.189614_bb0520","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41423-024-01232-z","article-title":"Targeting of TAMs: can we be more clever than cancer cells?","volume":"21","author":"Kzhyshkowska","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0525","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1038\/s41467-024-49916-4","article-title":"Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome","volume":"15","author":"Guimar\u00e3es","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0530","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0535","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1038\/s41467-024-50478-8","article-title":"A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0540","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189614_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112732","article-title":"Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma","volume":"42","author":"Patterson","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189614_bb0550","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41467-023-36296-4","article-title":"Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment","volume":"14","author":"Werba","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0555","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1038\/s41467-025-59529-0","article-title":"SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases","volume":"16","author":"Trehan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0560","article-title":"CTHRC1+ fibroblasts and SPP1+ macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189614_bb0565","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s41590-023-01579-x","article-title":"Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC","volume":"24","author":"Baer","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0570","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","article-title":"Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0575","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0580","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/j.gastro.2025.01.244","article-title":"TREM2 depletion in pancreatic cancer elicits pathogenic inflammation and accelerates tumor progression via enriching IL-1\u03b2+ macrophages","volume":"168","author":"Yang","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0585","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0590","first-page":"1185","article-title":"TNF-\u03b1-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer","volume":"2","author":"Tu","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189614_bb0595","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41467-024-55330-7","article-title":"Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer","volume":"16","author":"Klein","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0600","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/gutjnl-2024-333492","article-title":"Induction of macrophage efferocytosis in pancreatic cancer via PI3K\u03b3 inhibition and radiotherapy promotes tumour control","volume":"74","author":"Russell","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb0605","first-page":"774","article-title":"Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis","volume":"5","author":"Astuti","year":"2024","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189614_bb0610","first-page":"OF1","article-title":"Targeting interactions between siglec-10 and \u03b13\u03b21 integrin enhances macrophage-mediated phagocytosis of pancreatic cancer","author":"Saini","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0615","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl5800","article-title":"Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice","volume":"17","author":"Chen","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0620","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-17-2283","article-title":"CD47 blockade as an adjuvant immunotherapy for resectable pancreatic cancer","volume":"24","author":"Michaels","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0625","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1158\/1078-0432.CCR-14-1399","article-title":"Inhibition of CD47 effectively targets pancreatic cancer stem cells via dual mechanisms","volume":"21","author":"Cioffi","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0630","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1038\/s41467-024-49825-6","article-title":"An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0635","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1136\/gutjnl-2023-331854","article-title":"DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer","volume":"73","author":"Brichkina","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb0640","article-title":"Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189614_bb0645","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212062","article-title":"Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy","volume":"220","author":"Zuo","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-023-01388-7","article-title":"Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer","volume":"22","author":"Hussain","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2026.189614_bb0655","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/j.gastro.2016.02.070","article-title":"Radiation therapy induces macrophages to suppress T-cell responses against pancreatic tumors in mice","volume":"150","author":"Seifert","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0660","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0665","article-title":"CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1","volume":"6","author":"van Laethem","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0670","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2021.09.066","article-title":"Activating immune recognition in pancreatic ductal adenocarcinoma via autophagy inhibition, MEK blockade, and CD40 agonism","volume":"162","author":"Jiang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0675","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1470-2045(20)30532-5","article-title":"CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study","volume":"22","author":"O'Hara","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0680","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0685","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s10147-016-0975-z","article-title":"The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases","volume":"21","author":"Arima","year":"2016","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0690","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/cam4.3695","article-title":"Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma","volume":"10","author":"Naso","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0695","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MPA.0000000000000271","article-title":"Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma","volume":"44","author":"Ben","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2026.189614_bb0700","doi-asserted-by":"crossref","first-page":"74314","DOI":"10.18632\/oncotarget.11031","article-title":"Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC)","volume":"7","author":"Tao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189614_bb0705","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.hpb.2017.10.011","article-title":"Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer","volume":"20","author":"Chawla","year":"2018","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.bbcan.2026.189614_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11020113","article-title":"Cohort analysis of ADAM8 Expression in the PDAC tumor stroma","volume":"11","author":"Jaworek","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0715","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13046-024-03178-6","article-title":"Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma","volume":"43","author":"Luo","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217327","article-title":"Local ablation disrupts immune evasion in pancreatic cancer","volume":"609","author":"Musiu","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189614_bb0725","article-title":"A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy","volume":"14","author":"Shao","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189614_bb0730","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1180810","article-title":"Neutrophil diversity in inflammation and cancer","volume":"14","author":"Carnevale","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104763","article-title":"Subtypes of tumor-associated neutrophils and their roles in cancer immunotherapy","volume":"212","author":"Chu","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0740","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005798","article-title":"Prognostic value of tumor-associated N1\/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma","volume":"10","author":"Chen","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0745","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7150\/ijbs.14996","article-title":"Neutrophil-derived proteases in the microenvironment of pancreatic cancer -active players in tumor progression","volume":"12","author":"Felix","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2026.189614_bb0750","doi-asserted-by":"crossref","DOI":"10.2174\/0113892010365485250330110031","article-title":"Molecular mechanisms of immune resistance in pancreatic cancer: an update","author":"Pang","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0755","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2018.05.024","article-title":"Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis","volume":"501","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0760","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.7150\/jca.35443","article-title":"High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma","volume":"10","author":"Liu","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0765","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143339","article-title":"Neutrophil extracellular traps and pancreatic cancer development: a vicious cycle","volume":"14","author":"Mitsis","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189614_bb0770","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2073785","article-title":"Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils","volume":"14","author":"Tan","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2026.189614_bb0775","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0780","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/17474124.2024.2412045","article-title":"Metabolites derived from gut microbiota mitigate chemoresistance in pancreatic cancer","volume":"18","author":"Deng","year":"2024","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0785","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/imm.13765","article-title":"Tumour-associated neutrophils: potential therapeutic targets in pancreatic cancer immunotherapy","volume":"172","author":"Wu","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0790","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0795","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0800","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic Ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0805","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0810","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"Ohlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0815","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","article-title":"Classifying cancer-associated fibroblasts-the good, the bad, and the target","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0820","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"Ozdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0825","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb0830","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0835","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","article-title":"Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer","volume":"40","author":"Nicolas","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0840","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189614_bb0845","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb0850","article-title":"Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbcan.2026.189614_bb0855","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1073\/pnas.1214136110","article-title":"Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury","volume":"110","author":"Li","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189614_bb0860","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ncb2610","article-title":"Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature","volume":"14","author":"Rinkevich","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0865","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2024.07.008","article-title":"Gluten-dependent activation of CD4+ T cells by MHC class II-expressing epithelium","volume":"167","author":"Rahmani","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0870","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/IGC.0000000000000697","article-title":"Human peritoneal mesothelial cells display phagocytic and antigen-presenting functions to contribute to intraperitoneal immunity","volume":"26","author":"Shaw","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0875","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210815","article-title":"Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts","volume":"219","author":"Kerdidani","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0880","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0885","article-title":"Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially control regulatory T cell phenotype and function via CXCL9 and CCL22","author":"Maru","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbcan.2026.189614_bb0890","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0895","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189614_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189614_bb0905","article-title":"Interferon-\u03b3-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer","volume":"6","author":"Cao","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb0910","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/1878-0261.12905","article-title":"IFN\u03b21 secreted by breast cancer cells undergoing chemotherapy reprograms stromal fibroblasts to support tumour growth after treatment","volume":"15","author":"Maia","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0915","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","article-title":"TGF\u03b2-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb0920","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.it.2012.04.006","article-title":"Tertiary lymphoid organs in infection and autoimmunity","volume":"33","author":"Neyt","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0925","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0105-2896.2009.00861.x","article-title":"Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage\/remodeling","volume":"233","author":"Manzo","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189614_bb0930","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value regulation, and manipulation for therapeutic intervention","volume":"7","author":"Saut\u00e8s-Fridman","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0935","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0940","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-13-2590","article-title":"Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers","volume":"20","author":"Di Caro","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0945","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1378844","article-title":"Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer","volume":"7","author":"Posch","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0950","first-page":"3275","article-title":"Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas","volume":"63","author":"Nzula","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb0955","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1512458","article-title":"B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies","volume":"8","author":"Schl\u00f6\u00dfer","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189614_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.678127","article-title":"B cell orchestration of anti-tumor immune responses: a matter of cell localization and communication","volume":"9","author":"Kinker","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0965","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/d41586-019-03943-0","article-title":"New predictors for immunotherapy responses sharpen our view of the tumour microenvironment","volume":"577","author":"Bruno","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0970","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0975","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0046-8177(93)90235-9","article-title":"Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy","volume":"24","author":"Genta","year":"1993","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2026.189614_bb0980","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/bjc.2015.145","article-title":"Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer","volume":"112","author":"Hiraoka","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb0985","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb0990","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","article-title":"IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer","volume":"638","author":"Amisaki","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb0995","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41591-022-01829-9","article-title":"Sotigalimab and\/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial","volume":"28","author":"Padr\u00f3n","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb1000","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2326-6066.CIR-14-0027","article-title":"Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation","volume":"2","author":"Lutz","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb1005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189614_bb1010","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb1020","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","article-title":"The role of extracellular vesicles in cancer","volume":"186","author":"Kalluri","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb1025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb1030","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1038\/s41467-025-63718-2","article-title":"Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates","volume":"16","author":"Kalluri","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb1035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091493","article-title":"M1 macrophage-derived exosomes loaded with gemcitabine and deferasirox against chemoresistant pancreatic cancer","volume":"13","author":"Zhao","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2026.189614_bb1040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","article-title":"Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189614_bb1045","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189614_bb1050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.trecan.2020.03.007","article-title":"Exosomes as a multicomponent biomarker platform in cancer","volume":"6","author":"LeBleu","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb1055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2023.11.003","article-title":"Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer","volume":"97","author":"Vahabi","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1060","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gutjnl-2020-323014","article-title":"Exosome-delivered CD44v6\/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment","volume":"71","author":"Xie","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb1070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06114-4","article-title":"Tumour extracellular vesicles and particles induce liver metabolic dysfunction","volume":"618","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb1075","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1016\/j.cell.2024.09.024","article-title":"Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer","volume":"187","author":"You","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb1080","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/gutjnl-2021-324994","article-title":"Extracellular vesicles from pancreatic cancer stem cells lead an intratumor communication network (EVNet) to fuel tumour progression","volume":"71","author":"Ruivo","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb1085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb1090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1158\/2159-8290.CD-22-0876","article-title":"Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer","volume":"13","author":"Falcomat\u00e0","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb1095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43556-025-00280-9","article-title":"Exosomes in inflammation and cancer: from bench to bedside applications","volume":"6","author":"Huang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bbcan.2026.189614_bb1100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/cmi.2016.34","article-title":"HMGB1, IL-1\u03b1, IL-33 and S100 proteins: dual-function alarmins","volume":"14","author":"Bertheloot","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1105","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41423-024-01195-1","article-title":"BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells","volume":"21","author":"Alashkar Alhamwe","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-020-2015-4","article-title":"ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity","volume":"579","author":"Moral","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb1115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153242","article-title":"Targeting TNF-\u03b1-producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling","volume":"7","author":"Dixit","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2026.189614_bb1120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13046-024-03129-1","article-title":"IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cells","volume":"43","author":"Gambardella","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb1125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41586-020-03147-x","article-title":"A gene-environment-induced epigenetic program initiates tumorigenesis","volume":"590","author":"Alonso-Curbelo","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb1130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb1135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccell.2019.11.004","article-title":"The tumor microbiome in pancreatic cancer: bacteria and beyond","volume":"36","author":"McAllister","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb1140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcancer.2025.03.002","article-title":"The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer","volume":"112","author":"Daniel","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1145","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.trecan.2019.10.005","article-title":"Harnessing the microbiome for pancreatic cancer immunotherapy","volume":"5","author":"Vitiello","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb1150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189614_bb1155","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2374596","article-title":"Microbiome and pancreatic cancer: time to think about chemotherapy","volume":"16","author":"de Castilhos","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2026.189614_bb1160","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1084\/jem.20142162","article-title":"TLR9 ligation in pancreatic stellate cells promotes tumorigenesis","volume":"212","author":"Zambirinis","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb1165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb1170","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.pan.2023.07.008","article-title":"Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma","volume":"23","author":"Pfisterer","year":"2023","journal-title":"Pancreatol. Offic. J. Int. Assoc. Pancreatol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1175","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189614_bb1180","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189614_bb1185","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb1190","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189614_bb1195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Re\u017een","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2026.189614_bb1200","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.ymthe.2025.03.005","article-title":"From concept to cure: the evolution of CAR-T cell therapy","volume":"33","author":"Patel","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2026.189614_bb1205","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1002\/cam4.3870","article-title":"Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients","volume":"10","author":"Mohindroo","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb1210","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.3748\/wjg.v28.i32.4698","article-title":"International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: a joinpoint regression analysis","volume":"28","author":"Ilic","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113471","article-title":"Risk factors for early-onset pancreatic ductal adenocarcinoma: a systematic literature review","volume":"198","author":"Chandana","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb1220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2025.05.004","article-title":"The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC","volume":"113","author":"Peduzzi","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116818","article-title":"Detection and quantification of microplastics in various types of human tumor tissues","volume":"283","author":"Zhao","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.bbcan.2026.189614_bb1230","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-024-03165-6","article-title":"Western diets and chronic diseases","volume":"30","author":"Adolph","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb1235","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-med-051613-012328","article-title":"Impact of the obesity epidemic on cancer","volume":"66","author":"Goodwin","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbcan.2026.189614_bb1240","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081593","article-title":"Upregulated matrisomal proteins and extracellular matrix mechanosignaling underlie obesity-associated promotion of pancreatic ductal adenocarcinoma","volume":"16","author":"Waldron","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189614_bb1245","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5665964","article-title":"Diet-induced obesity promotes liver metastasis of pancreatic ductal adenocarcinoma via CX3CL1\/CX3CR1 axis","volume":"2022","author":"Sun","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb1250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-nutr-062220-025831","article-title":"Dietary fructose and fructose-induced pathologies","volume":"42","author":"Jung","year":"2022","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.bbcan.2026.189614_bb1255","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1158\/0008-5472.CAN-23-0464","article-title":"Fructose-induced mTORC1 activation promotes pancreatic cancer progression through inhibition of autophagy","volume":"83","author":"Cui","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189614_bb1260","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1111\/cas.13766","article-title":"Fatty pancreas: a possible risk factor for pancreatic cancer in animals and humans","volume":"109","author":"Takahashi","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189614_bb1265","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000832","article-title":"Pancreatic steatosis as a risk factor for pancreatic ductal adenocarcinoma: pathogenesis and clinical implications","volume":"16","author":"Papalamprakopoulou","year":"2025","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1270","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2013.08.018","article-title":"A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice","volume":"145","author":"Philip","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189614_bb1275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tjnut.2024.10.054","article-title":"Dietary \u03c9-3 fatty acids mitigate intestinal barrier integrity alterations in mice fed a high-fat diet: implications for pancreatic carcinogenesis","volume":"155","author":"Machuca","year":"2025","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbcan.2026.189614_bb1280","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/s41467-022-30392-7","article-title":"Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPAR\u03b4","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189614_bb1285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2015.02.002","article-title":"Four types of fatty acids exert differential impact on pancreatic cancer growth","volume":"360","author":"Yu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189614_bb1290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113096","article-title":"Pancreatic cancer (PDAC): introduction of evidence-based complementary measures into integrative clinical management","volume":"12","author":"Jentzsch","year":"2020","journal-title":"cancers"},{"key":"10.1016\/j.bbcan.2026.189614_bb1295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241186","article-title":"Docosahexaenoic acid inhibits the proliferation of Kras\/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis","volume":"15","author":"Hung","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189614_bb1300","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030370","article-title":"Eicosapentaenoic acid inhibits KRAS mutant pancreatic cancer cell growth by suppressing hepassocin expression and STAT3 phosphorylation","volume":"11","author":"Chiu","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2026.189614_bb1305","doi-asserted-by":"crossref","DOI":"10.3390\/nu15204465","article-title":"Pancreatic ductal adenocarcinoma and nutrition: exploring the role of diet and gut health","volume":"15","author":"Gualtieri","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bbcan.2026.189614_bb1310","article-title":"Vitamin C suppresses pancreatic carcinogenesis through the inhibition of both glucose metabolism and Wnt signaling","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189614_bb1315","first-page":"2212","article-title":"Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest","volume":"18","author":"Cenigaonandia-Campillo","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1320","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4251\/wjgo.v15.i6.943","article-title":"Vitamin E in the management of pancreatic cancer: a scoping review","volume":"15","author":"Ekeuku","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.bbcan.2026.189614_bb1325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11912-023-01370-z","article-title":"Complementary and Integrative Medicine in Pancreatic Cancer","volume":"25","author":"Frenkel","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189614_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110116","article-title":"Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NF\u03baB activation","volume":"127","author":"Qian","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2026.189614_bb1335","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13430-z","article-title":"Exclusive and combined use of statins and aspirin and the risk of pancreatic cancer: a case-control study","volume":"7","author":"Archibugi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189614_bb1340","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/gutjnl-2015-310442","article-title":"Reduced risk of pancreatic cancer associated with asthma and nasal allergies","volume":"66","author":"Gomez-Rubio","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189614_bb1345","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.35397","article-title":"Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk","volume":"157","author":"He","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189614_bb1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2025.101991","article-title":"The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer","volume":"74","author":"Lauri","year":"2025","journal-title":"Best Pract. Res. Clin. Gastroenterol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:40:26Z","timestamp":1785073226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":270,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X26000867"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189614","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging concepts, hot topics, and open questions in today\u2019s pancreatic cancer research","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189614"}}